Resmed Inc Stock Cash And Equivalents
| RMD Stock | USD 243.60 2.05 0.85% |
ResMed Inc fundamentals help investors to digest information that contributes to ResMed's financial success or failures. It also enables traders to predict the movement of ResMed Stock. The fundamental analysis module provides a way to measure ResMed's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ResMed stock.
| Last Reported | Projected for Next Year | ||
| Cash And Equivalents | 246.3 M | 254.8 M |
ResMed | Cash And Equivalents |
ResMed Inc Company Cash And Equivalents Analysis
ResMed's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current ResMed Cash And Equivalents | 273.71 M |
Most of ResMed's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ResMed Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
ResMed Cash And Equivalents Driver Correlations
Understanding the fundamental principles of building solid financial models for ResMed is extremely important. It helps to project a fair market value of ResMed Stock properly, considering its historical fundamentals such as Cash And Equivalents. Since ResMed's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of ResMed's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of ResMed's interrelated accounts and indicators.
Click cells to compare fundamentals
ResMed Cash And Equivalents Historical Pattern
Today, most investors in ResMed Stock are looking for potential investment opportunities by analyzing not only static indicators but also various ResMed's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's cash and equivalents growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of ResMed cash and equivalents as a starting point in their analysis.
ResMed Cash And Equivalents |
| Timeline |
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, ResMed Inc has 273.71 M in Cash And Equivalents. This is 66.66% lower than that of the Health Care Equipment & Supplies sector and 12.82% lower than that of the Health Care industry. The cash and equivalents for all United States stocks is 89.87% higher than that of the company.
ResMed Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ResMed's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ResMed could also be used in its relative valuation, which is a method of valuing ResMed by comparing valuation metrics of similar companies.ResMed is currently under evaluation in cash and equivalents category among its peers.
ResMed ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, ResMed's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to ResMed's managers, analysts, and investors.Environmental | Governance | Social |
ResMed Fundamentals
| Return On Equity | 0.24 | ||||
| Return On Asset | 0.13 | ||||
| Profit Margin | 0.23 % | ||||
| Operating Margin | 0.32 % | ||||
| Current Valuation | 35.88 B | ||||
| Shares Outstanding | 146.8 M | ||||
| Shares Owned By Insiders | 0.77 % | ||||
| Shares Owned By Institutions | 61.20 % | ||||
| Number Of Shares Shorted | 7.89 M | ||||
| Price To Earning | 73.48 X | ||||
| Price To Book | 6.83 X | ||||
| Price To Sales | 7.44 X | ||||
| Revenue | 4.69 B | ||||
| Gross Profit | 2.39 B | ||||
| EBITDA | 1.6 B | ||||
| Net Income | 1.02 B | ||||
| Cash And Equivalents | 273.71 M | ||||
| Cash Per Share | 1.87 X | ||||
| Total Debt | 873.93 M | ||||
| Debt To Equity | 0.27 % | ||||
| Current Ratio | 2.80 X | ||||
| Book Value Per Share | 35.39 X | ||||
| Cash Flow From Operations | 1.4 B | ||||
| Short Ratio | 7.18 X | ||||
| Earnings Per Share | 7.55 X | ||||
| Price To Earnings To Growth | 1.83 X | ||||
| Target Price | 253.39 | ||||
| Beta | 0.69 | ||||
| Market Capitalization | 35.76 B | ||||
| Total Asset | 6.87 B | ||||
| Retained Earnings | 4.99 B | ||||
| Working Capital | 1.45 B | ||||
| Current Asset | 1.42 B | ||||
| Current Liabilities | 637.99 M | ||||
| Annual Yield | 0.01 % | ||||
| Five Year Return | 1.02 % | ||||
| Net Asset | 6.87 B | ||||
| Last Dividend Paid | 1.97 |
About ResMed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ResMed Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ResMed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ResMed Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether ResMed Inc is a strong investment it is important to analyze ResMed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ResMed's future performance. For an informed investment choice regarding ResMed Stock, refer to the following important reports:Check out ResMed Piotroski F Score and ResMed Altman Z Score analysis. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ResMed. If investors know ResMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ResMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.416 | Dividend Share 1.97 | Earnings Share 7.55 | Revenue Per Share 32.711 | Quarterly Revenue Growth 0.111 |
The market value of ResMed Inc is measured differently than its book value, which is the value of ResMed that is recorded on the company's balance sheet. Investors also form their own opinion of ResMed's value that differs from its market value or its book value, called intrinsic value, which is ResMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ResMed's market value can be influenced by many factors that don't directly affect ResMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ResMed's value and its price as these two are different measures arrived at by different means. Investors typically determine if ResMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.